Apigenin Attenuates Experimental Autoimmune Myocarditis by Modulating Th1/Th2 Cytokine Balance in Mice

Inflammation

Volumn 39, Issue 2, 2016, Pages 678-686

  Zhang, Shouxin ^a   Liu, Xiaoyan ^a   Sun, Chengming ^a   Yang, Jun ^a   Wang, Lihong ^a   Liu, Jie ^a   Gong, Lei ^a   Jing, Yanyan ^a  

^a YANTAI YUHUANGDING HOSPITAL   (China)

Author keywords

apigenin; experimental autoimmune myocarditis; inflammation; myosin; Th1 Th2 cytokine balance

Indexed keywords

APIGENIN; CARDIAC MYOSIN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE; IL10 PROTEIN, MOUSE; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; ECHOCARDIOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL AUTOIMMUNE MYOCARDITIS; HEART FUNCTION; HEART LEFT VENTRICLE FAILURE; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE REMODELING; HEART WEIGHT; HISTOPATHOLOGY; IMMUNOMODULATION; INFLAMMATORY INFILTRATE; LOW DRUG DOSE; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; MOUSE MODEL; NONHUMAN; TH1 TH2 BALANCE; UPREGULATION; ANIMAL; AUTOIMMUNE DISEASES; BAGG ALBINO MOUSE; BIOSYNTHESIS; BLOOD; CARDIOMEGALY; CELL PROLIFERATION; CHEMICALLY INDUCED; DRUG EFFECTS; IMMUNOLOGY; MYOCARDITIS; TH1 CELL; TH2 CELL;

ANIMALS; APIGENIN; AUTOIMMUNE DISEASES; CARDIAC MYOSINS; CARDIOMEGALY; CELL PROLIFERATION; CYTOKINES; ECHOCARDIOGRAPHY; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-2; INTERLEUKIN-4; MALE; MICE; MICE, INBRED BALB C; MYOCARDITIS; TH1 CELLS; TH1-TH2 BALANCE; TH2 CELLS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84949660514     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-015-0294-y     Document Type: Article

References (36)

1. Feldman, A.M., and D. McNamara. 2000. Myocarditis. New England Journal of Medicine 343(19): 1388–1398.
2. Levi, D., and J. Alejos. 2001. Diagnosis and treatment of pediatric viral myocarditis. Current Opinion in Cardiology 16(2): 77–83.
3. Shimada, K., T.A. Okabe, Y. Mikami, M. Hattori, M. Fujita, and C. Kishimoto. 2010. Therapy with granulocyte colony-stimulating factor in the chronic stage, but not in the acute stage, improves experimental autoimmune myocarditis in rats via nitric oxide. Journal of Molecular and Cellular Cardiology 49(3): 469–481. doi:10.1016/j.yjmcc.2010.02.003.
4. Kim, K.S., G. Hufnagel, N.M. Chapman, and S. Tracy. 2001. The group B coxsackie viruses and myocarditis. Reviews in Medical Virology 11(6): 355–368.
5. Fairweather, D., Z. Kaya, G.R. Shellam, C.M. Lawson, and N.R. Rose. 2001. From infection to autoimmunity. Journal of Autoimmunity 16(3): 175–186.
6. Cunningham, M.W. 2004. T cell mimicry in inflammatory heart disease. Molecular Immunology 40(14–15): 1121–1127.
7. Cooper Jr., L.T. 2009. Myocarditis. N Engl J Med 360: 1526–1538.
8. Kodama, M., H. Hanawa, M. Saeki, H. Hosono, T. Inomata, K. Suzuki, and A. Shibata. 1994. Rat dilated cardiomyopathy after autoimmune giant cell myocarditis. Circulation Research 75(2): 278–284.
9. Arumugam, S., R.A. Thandavarayan, P.T. Veeraveedu, V.V. Giridharan, V. Soetikno, M. Harima, K. Suzuki, M. Nagata, R. Tagaki, M. Kodama, and K. Watanabe. 2012. Involvement of AMPK and MAPK signaling during the progression of experimental autoimmune myocarditis in rats and its blockade using a novel antioxidant. Experimental and Molecular Pathology 93(2): 183–189. doi:10.1016/j.yexmp.2012.04.012.
10. Neu, N., N.R. Rose, K.W. Beisel, A. Herskowitz, G. Gurri-Glass, and S.W. Craig. 1987. Cardiac myosin induces myocarditis in genetically predisposed mice. Journal of Immunology 139(11): 3630–3636.
11. Pummerer, C.L., K. Luze, G. Grassl, K. Bachmaier, F. Offner, S.K. Burrell, D.M. Lenz, T.J. Zamborelli, J.M. Penninger, and N. Neu. 1996. Identification of cardiac myosin peptides capable of inducing autoimmune myocarditis in BALB/c mice. Journal of Clinical Investigation 97(9): 2057–2062.
12. Kodama, M., Y. Matsumoto, and M. Fujiwara. 1992. In vivo lymphocyte mediated myocardial injuries demonstrated by adoptive transfer of experimental autoimmune myocarditis. Circulation 85(5): 1918–1926.
13. Kishimoto, C., T.A. Okabe, M. Hattori, and Z. Yuan. 2008. Naloxone, an opiate receptor antagonist, ameliorates acute experimental autoimmune myocarditis by reducing cytotoxic activities. Journal of Cardiovascular Pharmacology 52(5): 445–451. doi:10.1097/FJC.0b013e31818c8605.
14. Smith, S.C., and P.M. Allen. 1991. Myosin-induced acute myocarditis is a T cell-mediated disease. Journal of Immunology 147(7): 2141–2147.
15. Tang, F., F. Wang, L. An, and X. Wang. 2015. Upregulation of Tim-3 on CD4+ T cells is associated with Th1/Th2 imbalance in patients with allergic asthma. Intenational Journal Clinical Experimental Medicine 8(3): 3809–3816.
16. Barnes, A.G., V. Cerovic, P.S. Hobson, and L.S. Klavinskis. 2007. Bacillus subtilis spores: a novel microparticle adjuvant which can instruct a balanced Th1 and Th2 immune response to specific antigen. European Journal of Immunology 37(6): 1538–1547.
17. Liu, Y., F. Jiao, Y. Qiu, W. Li, F. Lao, G. Zhou, B. Sun, G. Xing, J. Dong, Y. Zhao, Z. Chai, and C. Chen. 2009. The effect of Gd@ C 82 (OH) 22 nanoparticles on the release of Th1/Th2 cytokines and induction of TNF-α mediated cellular immunity. Biomaterials 30(23–24): 3934–3945. doi:10.1016/j.biomaterials.2009.04.001.
18. Martín, R., C. Cordova, J.A. San Román, B. Gutierrez, V. Cachofeiro, and M.L. Nieto. 2014. Oleanolic acid modulates the immune-inflammatory response in mice with experimental autoimmune myocarditis and protects from cardiac injury. Therapeutic implications for the human disease. Journal of Molecular and Cellular Cardiology 72: 250–262. doi:10.1016/j.yjmcc.2014.04.002.
19. Sharma, H., R. Kanwal, N. Bhaskaran, and S. Gupta. 2014. Plant flavone apigenin binds to nucleic acid bases and reduces oxidative DNA damage in prostate epithelial cells. PLoS One 9: e91588. doi:10.1371/journal.pone.0091588.
20. Tahanian, E., L.A. Sanchez, T.C. Shiao, R. Roy, and B. Annabi. 2011. Flavonoids targeting of IκB phosphorylation abrogates carcinogen-induced MMP-9 and COX-2 expression in human brain endothelial cells. Drug Design Development and Therapy 5: 299–309. doi:10.2147/DDDT.S19931.
21. Fu, M.S., B.J. Zhu, and D.W. Luo. 2014. Apigenin prevents TNF-α induced apoptosis of primary rat retinal ganglion cells. Cellular and Molecular Biology 60(4): 37–42.
22. Gupta, S., F. Afaq, and H. Mukhtar. 2002. Involvement of nuclear factor-kappa B, Bax and Bcl-2 in induction of cell cycle arrest and apoptosis by apigenin in human prostatecarcinoma cells. Oncogene 21(23): 3727–3738.
23. Kanazawa, K., M. Uehara, H. Yanagitani, and T. Hashimoto. 2006. Bioavailable flavonoids to suppress the formation of 8-OHdG in HepG2 cells. Archives of Biochemistry and Biophysics 455: 197–203.
24. Ha, S.K., P. Lee, J.A. Park, H.R. Oh, S.Y. Lee, J.H. Park, E.H. Lee, J.H. Ryu, K.R. KR, and S.Y. Kim. 2008. Apigenin inhibits the production of NO and PGE 2 in microglia and inhibits neuronal cell death in a middle cerebral artery occlusion-induced focal ischemia mice model. Neurochemistry International 52(4–5): 878–886.
25. Zhang, F., F. Li, and G. Chen. 2014. Neuroprotective effect of apigenin in rats after contusive spinal cord injury. Neurological Sciences 35(4): 583–588. doi:10.1007/s10072-013-1566-7.
26. Patil, S.P., P.D. Jain, J.S. Sancheti, P.J. Ghumatkar, R. Tambe, and S. Sathaye. 2014. Neuroprotective and neurotrophic effects of Apigenin and Luteolin in MPTP induced parkinsonism in mice. Neuropharmacology 86: 192–202. doi:10.1016/j.neuropharm.2014.07.012.
27. Shioi, T., P.M. Kang, P.S. Douglas, J. Hampe, C.M. Yballe, J. Lawitts, L.C. Cantley, and S. Izumo. 2000. The conserved phosphoinositide 3-kinase pathway determines heart size in mice. EMBO Journal 19(11): 2537–2548.
28. Milenković, M., N. Arsenović-Ranin, Z. Stojić-Vukanić, B. Bufan, D. Vučićević, and I. Jančić. 2010. Quercetin ameliorates experimental autoimmune myocarditis in rats. Journal of Pharmacy and Pharmaceutical Sciences 2010; 13(3): 311–319.
29. Bergelson, J.M., J.A. Cunningham, G. Droguett, E.A. Kurt-Jones, A. Krithivas, J.S. Hong, M.S. Horwitz, R.L. Crowell, and R.W. Finberg. 1997. Isolation of common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science 275(5304): 1320–1323.
30. Springer, T.A. 1994. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76(2): 301–314.
31. Liu, X., X. Zhu, A. Wang, H. Fan, and H. Yuan. 2009. Effects of angiotensin-II receptor blockers on experimental autoimmune myocarditis. International Journal of Cardiology 137(3): 282–288. doi:10.1016/j.ijcard.2009.09.540.
32. Kishimoto, C., Y. Kuroki, Y. Hiraoka, H. Ochiai, M. Kurokawa, and S. Sasayama. 1994. Cytokine and murine coxsackievirus B3 myocarditis. Interleukin-2 suppressed myocarditis in the acute stage but enhanced the condition in the subsequent stage. Circulation 89(6): 2836–2842.
33. Liu, X., B. Li, W. Wang, C. Zhang, M. Zhang, Y. Zhang, Y. Xia, Z. Dong, Y. Guo, and F. An. 2012. Effects of HMG-CoA reductase inhibitor on experimental autoimmune myocarditis. Cardiovascular Drugs and Therapy 26(2): 121–130. doi:10.1007/s10557-012-6372-6.
34. Smith, S.C., and P.M. Allen. 1992. Neutralization of endogenous tumor necrosis factor ameliorates the severity of myosin-induced myocarditis. Circulation Research 70(4): 856–863.
35. Yang, S., W. Li, W. Liu, C. Gao, B. Zhou, S. Li, Y. Li, and Y. Kong. 2006. IL-10 gene modified dendritic cells induced antigen-specific tolerance in experimental autoimmune myocarditis. Clinical Immunology 121(1): 63–73.
36. Sukumaran, V., P.T. Veeraveedu, N. Gurusamy, A.P. Lakshmanan, K. Yamaguchi, M. Ma, K. Suzuki, M. Nagata, R. Takagi, M. Kodama, and K. Watanabe. 2012. Olmesartan attenuates the development of heart failure after experimental autoimmune myocarditis in rats through the modulation of ANG 1–7 mas receptor. Molecular and Cellular Endocrinology 351(2): 208–219. doi:10.1016/j.mce.2011.12.010.